Orlance Awarded 3.3M NIH Grant For MACH-1 Influenza Vaccine
10 Oct 2024 //
PR NEWSWIRE
Orlance Collaborates On MACH-1 System Development
16 May 2024 //
ACCESSWIRE
Orlance Awarded $3M NIH SBIR Grant for Advancing MACH-1 Needle-Free Vaccine
28 Nov 2023 //
PR NEWSWIRE